• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Retracted: Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.撤回：伊立替康联合奈达铂与紫杉醇联合顺铂在局部晚期宫颈癌新辅助化疗中的疗效及副作用与肿瘤标志物分析：基于一项回顾性分析
Comput Math Methods Med. 2023 Jun 28;2023:9869683. doi: 10.1155/2023/9869683. eCollection 2023.
2
Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.伊立替康联合奈达铂与紫杉醇联合顺铂新辅助化疗治疗局部晚期宫颈癌的疗效及不良反应比较：基于回顾性分析。
Comput Math Methods Med. 2022 Jun 1;2022:5936773. doi: 10.1155/2022/5936773. eCollection 2022.
3
Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).新辅助伊立替康和奈达铂治疗后行根治性子宫切除术及辅助化疗用于局部晚期、体积较大子宫颈癌的多机构II期研究：关西临床肿瘤学组研究（KCOG-G1201）
J Obstet Gynaecol Res. 2019 Mar;45(3):671-678. doi: 10.1111/jog.13885. Epub 2018 Dec 21.
4
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.奈达铂和紫杉醇新辅助化疗治疗局部晚期宫颈癌的毒性和长期疗效。
J Surg Oncol. 2012 Feb;105(2):206-11. doi: 10.1002/jso.22052. Epub 2011 Aug 3.
5
The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.新辅助化疗治疗局部晚期宫颈癌的疗效与安全性：一项随机多中心研究。
Gynecol Oncol. 2016 May;141(2):231-239. doi: 10.1016/j.ygyno.2015.06.027. Epub 2015 Jun 24.
6
Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?顺铂和紫杉醇化疗用于局部晚期宫颈癌：该方案在新辅助治疗中仍有作用吗？
Minerva Ginecol. 2012 Apr;64(2):95-107.
7
Neoadjuvant chemotherapy with liposomal paclitaxel plus platinum for locally advanced esophageal squamous cell cancer: Results from a retrospective study.局部晚期食管鳞癌的脂质体紫杉醇联合铂类新辅助化疗：一项回顾性研究结果。
Thorac Cancer. 2022 Mar;13(6):824-831. doi: 10.1111/1759-7714.14328. Epub 2022 Feb 4.
8
A modified shortened administration schedule for neoadjuvant chemotherapy with irinotecan and cisplatin in locally advanced cervical cancer.局部晚期宫颈癌中伊立替康和顺铂新辅助化疗的改良短程给药方案。
Int J Gynecol Cancer. 2011 May;21(4):685-9. doi: 10.1097/IGC.0b013e3182129b61.
9
Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.对晚期生殖细胞肿瘤患者采用紫杉醇、异环磷酰胺和顺铂联合挽救性化疗。
Int J Urol. 2015 Mar;22(3):288-93. doi: 10.1111/iju.12665. Epub 2014 Nov 13.
10
[Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].[紫杉醇联合顺铂或卡铂新辅助化疗用于局部晚期子宫颈癌患者]
Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):616-20.

本文引用的文献

1
Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.伊立替康联合奈达铂与紫杉醇联合顺铂新辅助化疗治疗局部晚期宫颈癌的疗效及不良反应比较：基于回顾性分析。
Comput Math Methods Med. 2022 Jun 1;2022:5936773. doi: 10.1155/2022/5936773. eCollection 2022.

撤回：伊立替康联合奈达铂与紫杉醇联合顺铂在局部晚期宫颈癌新辅助化疗中的疗效及副作用与肿瘤标志物分析：基于一项回顾性分析

Retracted: Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.

作者信息

Methods In Medicine Computational And Mathematical

出版信息

Comput Math Methods Med. 2023 Jun 28;2023:9869683. doi: 10.1155/2023/9869683. eCollection 2023.

DOI:10.1155/2023/9869683
PMID:37416124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10322336/
Abstract

[This retracts the article DOI: 10.1155/2022/5936773.].

摘要

[本文撤回文章DOI：10.1155/2022/5936773。]